|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0009429,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0524910,
umls-concept:C0556895,
umls-concept:C1274040,
umls-concept:C1514873,
umls-concept:C1546857,
umls-concept:C1549081,
umls-concept:C1556066,
umls-concept:C1619636,
umls-concept:C1692758
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-2-16
|
|
pubmed:abstractText |
Pegylated interferon/ribavirin (peg-IFN/RBV) combination therapy is effective for chronic hepatitis C (CHC) but frequently causes adverse events, leading to early termination. Little is known about the outcome of CHC patients who required early termination.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
pubmed-author:ChangWen-YuWY,
pubmed-author:ChenShinn-CherngSC,
pubmed-author:ChuangWan-LongWL,
pubmed-author:DaiChia-YenCY,
pubmed-author:HouNai-JenNJ,
pubmed-author:HsiehMing-YenMY,
pubmed-author:HsiehMing-YuhMY,
pubmed-author:HuangJee-FuJF,
pubmed-author:LeeLi-PoLP,
pubmed-author:LinZu-YouZY,
pubmed-author:WangLiang-YenLY,
pubmed-author:YuMing-LungML
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1015-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17302371-Adult,
pubmed-meshheading:17302371-Aged,
pubmed-meshheading:17302371-Drug Administration Schedule,
pubmed-meshheading:17302371-Drug Therapy, Combination,
pubmed-meshheading:17302371-Female,
pubmed-meshheading:17302371-Hepacivirus,
pubmed-meshheading:17302371-Hepatitis C, Chronic,
pubmed-meshheading:17302371-Humans,
pubmed-meshheading:17302371-Interferon-alpha,
pubmed-meshheading:17302371-Male,
pubmed-meshheading:17302371-Middle Aged,
pubmed-meshheading:17302371-Polyethylene Glycols,
pubmed-meshheading:17302371-Recombinant Proteins,
pubmed-meshheading:17302371-Ribavirin,
pubmed-meshheading:17302371-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Outcome of chronic hepatitis C patients who required early termination of pegylated interferon-alpha plus ribavirin combination therapy.
|
|
pubmed:affiliation |
Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
